Hypothyroidism and hypertension

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 11, 2010, Pages 1559-1565

  Stabouli, Stella ^a,b   Papakatsika, Sofia ^b   Kotsis, Vasilios ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

ambulatory blood pressure monitoring; blood pressure; hypothyroidism

Indexed keywords

LEVOTHYROXINE; N(G) NITROARGININE METHYL ESTER;

ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FORWARD HEART FAILURE; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; KIDNEY DYSFUNCTION; NONHUMAN; PREVALENCE; REVIEW; SYSTOLIC HYPERTENSION; VASCULAR RESISTANCE;

BLOOD PRESSURE; CARDIAC OUTPUT; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; HYPOTHYROIDISM; RENIN; THYROID HORMONES; VASCULAR RESISTANCE;

EID: 78649377785     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.141     Document Type: Review

References (73)

1. Klein I. Thyroid hormone and high blood pressure. In: Endocrine Mechanisms in Hypertension. Laragh JH, Brenner BM, Kaplan NM (Eds). Raven Press, NY, USA (1989).
2. Saito I, Ito K, Saruta T. Hypothyroidism as a cause of hypertension. Hypertension 5, 112-115 (1983).
3. Levey G, Klein I. Internal Medicine. Stein J (Ed.). Mosby, MO, USA, 1808 (1998).
4. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J. Clin. Endocrinol. Metab. 87, 1996-2000 (2002).
5. Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E, Aral Y. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J. Endocrinol. Invest. 27(10), 897-903 (2004).
6. Endo T, Komiya I, Tsukui T et al Re-evaluation of a possible high incidence of hypertension in hypothyroid patients. Am. Heart J. 98, 684-688 (1979).
7. Streeten DH, Anderson GH Jr, Howland T et al. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11, 78-83 (1988).
8. Bergus GR, Randall C, Van Peursem R. Lack of association between hypertension and hypothyroidism in postmenopausal women seen in a primary care setting. J. Am. Board Fam. Pract. 10, 185-191 (1997).
9. Bergus GR, Mold JW, Barton ED, Randall CS. The lack of association between hypertension and hypothyroidism in a primary care setting. J. Hum. Hypertens. 13, 231-235 (1999).
10. Iqbal A, Figenschau Y, Jorde R. Blood pressure in relation to serum thyrotropin: the Tromsø study. J. Hum. Hypertens. 20, 932-936 (2006).
11. Saltiki K, Voidonikola P, Stamatelopoulos K et al. Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-sectional study. Thyroid Res. 1(1), 3 (2008).
12. Kanbay M, Turgut F, Karakurt F et al. Relation between serum thyroid hormone and 'nondipper' circadian blood pressure variability. Kidney Blood Press. Res. 30, 416-420 (2007).
13. Liu D, Jiang F, Shan Z et al. A cross-sectional survey of relationship between serum TSH level and blood pressure. J. Hum. Hypertens. 24(2), 134-138 (2010).
14. Ojamaa K, Balkman C, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6, 505-512 (1996).
15. Bianco AC, Carvalho SD, Carvalho CR, Rabelo R, Moriscot AS. Thyroxine 5́-deiodination mediates norepinephrine-induced lipogenesis in dispersed brown adipocytes. Endocrinology 139(2), 571-578 (1998).
16. Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth. Analg. 85(4), 734-738 (1997).
17. Larsen PR, Berry MJ. Nutritional and hormonal regulation of thyroid hormone deiodinases. Annu. Rev. Nutr. 323-352 (1995).
18. Mizuma H, Murakami M, Mori M. Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ. Res. 88, 313-318 (2001).
19. Dagre AG, Lekakis JP, Papaioannou TG et al. Arterial stiffness is increased in subjects with hypothyroidism. Int. J. Cardiol. 103, 1-6 (2005).
20. Owen PJ, Sabit R, Lazarus JH. Thyroid disease and vascular function. Thyroid 17, 519-524 (2007).
21. Nagasaki T, Inaba M, Kumeda Y et al. Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91, 154-158 (2006).
22. Ichiki T. Thyroid hormone and atherosclerosis. Vascul. Pharmacol. 52, 151-156 (2010).
23. Obuobie K, Smith J, Evans M et al Increased central arterial stiffness in hypothyroidism. J. Clin. Endocrinol Metab. 87(10), 4662-4666 (2002).
24. Giannattasio C, Rivolta MR, Failla M, Magnoni AA, Stella ML, Mancia G. Large and medium sized artery abnormalities in untreated and treated hypothyroidism. Eur. Heart J. 18, 1492-1498 (1997).
25. Nagasaki T, Inaba M, Henmi Y et al Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin. Endocrinol. 59, 607-612 (2003).
26. Vargas F, Moreno JM, Rodríguez-Gómez I et al. Vascular and renal function in experimental thyroid disorders. Eur. J. Endocrinol. 154, 197-212 (2006).
27. Allon M, Harrow A, Pasque CB, Rodriguez M. Renal sodium and water handling in hypothyroid patients: the role of renal insuffciency. J. Am. Soc. Nephrol. 1, 205-210 (1990).
28. Iglesias P, Díez JJ. Thyroid dysfunction and kidney disease. Eur. J. Endocrinol 160, 503-515 (2009).
29. Vargas F, Atucha N, Sabio JM, Quesada T, García-Estãn J. Pressure diuresis-natriuresis response in hyper-and hypothyroid rats. Clin. Sci. 87, 323-328 (1994).
30. Montenegro M, González O, Saracho R, Aguirre R, González Ó, Martinez I. Changes in renal function in primary hypothyroidism. Am. J. Kidney Dis. 27, 195-198 (1996).
31. Panciera DL, Lefebvre HP. Effect of experimental hypothyroidism on glomerular fltration rate and plasma creatinine concentration in dogs. J. Vet. Intern. Med. 23, 1045-1050 (2009).
32. Van Welsem ME, Lobatto S. Treatment of severe hypothyroidism in a patient with progressive renal failure leads to signifcant improvement of renal function. Clin. Nephrol. 67, 391-393 (2007).
33. Iwazu Y, Nemoto J, Okuda K et al. A case of minimal change nephrotic syndrome with acute renal failure complicating Hashimoto's disease. Clin. Nephrol. 69, 47-52 (2008).
34. Valentín M, Bueno B, Gutiérrez E et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. Nefrologia 24(Suppl. 3), 43-48 (2004).
35. Atlas SA, Sealey JE, Larag JH, Moon C. Plasma renin and prorenin in essential hypertension during sodium depletion, p-blockade and reduced arterial pressure. Lancet 2, 785-789 (1977).
36. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl. J. Med. 344(7), 501-509 (2001).
37. Ganong WF. Thyroid hormones and renin secretion. Life Sci. 30, 561-569 (1982).
38. Klein I. Thyroid hormone and the cardiovascular system. Am. J. Med. 88, 631-637 (1990).
39. Kobori H, Hayashi M, Saruta T Thyroid hormone stimulates gene expression through the thyroid hormone response element. Hypertension 37, 99-104 (2001).
40. Marcisz C, Jonderko G, Kucharz EJ. Infuence of short-time application of a low sodium diet on blood pressure in patients with hyperthyroidism or hypothyroidism during therapy. Am. J. Hypertens. 14, 995-1002 (2001).
41. Gunasekera RD, Kuriyama H. The infuence of thyroid states upon responses of the rat aorta to catecholamines. Br. J. Pharmacol. 99, 541-547 (1990).
42. Foley CM, McAllister RM, Hasser EM. Thyroid status infuences barorefex function and autonomic contributions to arterial pressure and heart rate. Am. J. Physiol. Heart Circ. Physiol. 280, H2061-H2068 (2001).
43. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am. J. Med. 64, 613-621 (1978).
44. Kohno M, Murakawa K, Yasunari K, Nishizawa Y, Morii H, Takeda T Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism. Am. J. Med. 83, 648-652 (1987).
45. Vargas F, Sabio JM, Luna JD. Contribution of endothelium-derived relaxing factors to acetylholine-induced vasodilatation in the rat kidney. Cardiovasc. Res. 28, 1373-1377 (1994).
46. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144, 2179-2183 (2003).
47. Fukuyama K, Ichiki T, Takeda K et al. Down-regulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41, 598-603 (2003).
48. Hiroi Y, Kim HH, Ying H et al. Rapid nongenomic actions of thyroid hormone. Proc. Natl Acad. Sci. USA 103, 14104-14109 (2006).
49. Barreto-Chaves ML, Carrillo-Sepulveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the renin-angiotensin system. Vasc. Pharmacol. 52, 166-170 (2010).
50. Taddei S, Caraccio N, Virdis A et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: benefcial effect of levothyroxine therapy. J. Clin. Endocrinol. Metabol. 88, 3731-3737 (2003).
51. w-nitro-L- arginine. A potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 176, 219-223 (1990).
52. Imai T, Hirata Y, Iwashina M, Marumo F. Hormonal regulation of rat adrenomedullin gene in vasculature. Endocrinology 136(4), 1544-1548 (1995).
53. Diekman MJM, Harms MPM, Endert E, Wieling W, Wiersinga WM. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur. J. Endocrinol. 144, 339-346 (2001).
54. De Toledo FG, Cheng J, Dousa TP. Retinoic acid and triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 238, 847-850 (1997).
55. Zakopoulos NA, Nanas SN, Lekakis JP et al. Reproducibility of ambulatory blood pressure measurements in essential hypertension. Blood Press. Monit. 6, 41-45 (2001).
56. Clement DL, De Buyzere ML, De Bacquer DA et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348, 2407-2415 (2003).
57. Kotsis V, Alevizaki M, Stabouli S et al. Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study. J. Hypertens. 25, 993-999 (2007). (Pubitemid 46573118)
58. Benetos A. Pulse pressure and cardiovascular risk. J. Hypertens. Suppl. 17, S21-S24 (1999).
59. Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension 47, 137-138 (2006).
60. Parati G, Mancia G, Rienzo MD, Castiglioni P, Taylor JA, Studinger P. Cardiovascular variability is/is not an index of autonomic control of circulation. J. Appl. Physiol. 101, 690-691 (2006). (Pubitemid 44162395)
61. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr. Hypertens. Rep. 5(6), 513-520 (2003).
62. Botella-Carretero JI, Gómez-Bueno M, Barrios V et al. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr. Relat. Cancer 11, 345-356 (2004).
63. Hoshide S, Kario K, Hoshide Y et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 16, 434-438 (2003).
64. Ohkubo T, Hozawa A, Yamaguchi J et al. Prognostic signifcance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183-2189 (2002).
65. Biondi B, Cooper DS. The clinical signifcance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76-131 (2008).
66. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid 17(7), 625-630 (2007).
67. Nagasaki T, Inaba M, Yamada S et al. Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study. Eur. J. Endocrinol. 160, 409-415 (2009).
68. Canaris G, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch. Int. Med. 160(4), 526-534 (2000).
69. Danese MD, Landerson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 85, 2993-3001 (2000).
70. Kim SK, Kim SH, Park KS, Park SW, Cho Y W. Regression of the increased common carotid artery intima-media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocr. J. 56, 753-758 (2009).
71. Kvetny J, Hedgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade infammation, increased triglyceride levels and predicts cardiovascular risk in males below 50 years. Clin. Endocrinol. 61, 232-238 (2004).
72. Walsh JP, Bremner A P, Bulsara MK et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Int. Med. 165, 2467-2472 (2005).
73. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421-425 (2002).